- Home
- AREB vs XBIO Comparison
AREB vs XBIO Comparison
Compare AREB & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- XBIO
- Stock Information
- Founded
- AREB 2014
- XBIO N/A
- Country
- AREB United States
- XBIO United States
- Employees
- AREB N/A
- XBIO N/A
- Industry
- AREB Plastic Products
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- AREB Industrials
- XBIO Health Care
- Exchange
- AREB Nasdaq
- XBIO Nasdaq
- Market Cap
- AREB 6.8M
- XBIO 5.9M
- IPO Year
- AREB N/A
- XBIO N/A
- Fundamental
- Price
- AREB $1.05
- XBIO $2.35
- Analyst Decision
- AREB
- XBIO Hold
- Analyst Count
- AREB 0
- XBIO 1
- Target Price
- AREB N/A
- XBIO N/A
- AVG Volume (30 Days)
- AREB 1.2M
- XBIO 74.3K
- Earning Date
- AREB 11-10-2025
- XBIO 11-13-2025
- Dividend Yield
- AREB N/A
- XBIO N/A
- EPS Growth
- AREB N/A
- XBIO N/A
- EPS
- AREB N/A
- XBIO N/A
- Revenue
- AREB $9,014,691.00
- XBIO $2,858,935.00
- Revenue This Year
- AREB N/A
- XBIO $1.99
- Revenue Next Year
- AREB N/A
- XBIO $20.00
- P/E Ratio
- AREB N/A
- XBIO N/A
- Revenue Growth
- AREB N/A
- XBIO 13.30
- 52 Week Low
- AREB $0.91
- XBIO $2.20
- 52 Week High
- AREB $1,835.00
- XBIO $13.93
- Technical
- Relative Strength Index (RSI)
- AREB 41.45
- XBIO 37.40
- Support Level
- AREB $1.05
- XBIO $2.29
- Resistance Level
- AREB $1.14
- XBIO $2.72
- Average True Range (ATR)
- AREB 0.18
- XBIO 0.21
- MACD
- AREB 0.11
- XBIO -0.01
- Stochastic Oscillator
- AREB 19.79
- XBIO 15.17
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.